Senomyx Inc. (SNMX) Given Average Recommendation of “Hold” by Brokerages
Senomyx Inc. (NASDAQ:SNMX) has been assigned a consensus broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation.
Zacks has also given Senomyx an industry rank of 218 out of 255 based on the ratings given to its competitors.
In other news, major shareholder Senvest Management, Llc sold 2,689,504 shares of the stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $1.48, for a total value of $3,980,465.92. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 13.00% of the stock is owned by corporate insiders.
Shares of NASDAQ:SNMX traded down $0.01 during trading on Friday, hitting $1.50. The company’s stock had a trading volume of 48,300 shares, compared to its average volume of 237,214. Senomyx has a 12 month low of $0.80 and a 12 month high of $1.71. The stock has a market capitalization of $71.54 million, a PE ratio of -49.73 and a beta of 1.49.
Senomyx (NASDAQ:SNMX) last issued its quarterly earnings data on Thursday, August 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. Senomyx had a negative net margin of 9.11% and a negative return on equity of 15.80%. The firm had revenue of $3.29 million for the quarter.
Senomyx, Inc discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents.
Featured Story: What does the Dow Jones Industrial Average (DJIA) measure?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senomyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx and related companies with MarketBeat.com's FREE daily email newsletter.